Blog / Archives
Life Science News Update:$700M in Fed Research Center at NIH; AD Diagnosis
Will the GOP cut the NIH budget? Turf battles at the Institutes to follow. Who knew there were only two breakthroughs in mental health drugs: Thorazine and Lithium? Federal Research Center Will Help...
Biotech Movers du jour: Clinical Data (CLDA) and Genoptix (GXDX)
Novartis (NVS) acquires Genoptix(GXDX $24.84) for $470M-Stock is up 25% The biotech diagnostics and tools sector was ignited today with acquisition of Genoptix, a provider of laboratory services for...
Venture Capital Recovers, Biotechnology Gets $3.7B in 2010
Venture Capitalists invested $21.8B in 2010 an increase of 19% over the prior year. Biotechnology was up 3% over the prior year to $3.7B with 460 deals. Software was the leader rising 20% to $4B....
Rayno Life Science Portfolio 2011:Time to Raise a Little Cash
Time for Caution-Raise Cash After the Big Q4 2010 Run Here are some guidelines for the Rayno Life Science Portfolio: Smaller cap high beta biopharma stocks are at risk. No new buys. Our mid-cap...
Biotech Stocks Sell-Off On Profit Taking: Traders Rule
Small to Mid Caps Off 3%+ Our Mid-Cap Index of biotech stocks was off 3% and more today. Among the big movers down on significant volume were: Alkermes (ALKS) down 4.19%, Arena (ARNA) down 4.25%,...
Reporting from the JPMorgan 29th Annual Healthcare Conference 2011
J.P.Morgan 29th Annual Healthcare Conference San Francisco, CA January 9-13 2011 Biotechnology: Bright Prospects For 2011 Rod Raynovich The J.P.Morgan Healthcare Conference was a hot ticket in a...
Rayno Life Science Portfolio Review:Celera(CRA),Qiagen(QGEN),and Gilead(GILD)
Review of the Laggards Celera (CRA $6.09) has been a laggard primarily because of disappointing results from the recent acquisition of Berkeley Heart Labs(BHL) which had reported sales $20M vs $24M...
Rayno Snow Blog: High and Dry in the West
Did you ski a lot in December? We hope so because January has not delivered much precip since January 2. Mammoth had 13 in on Jan 1 and 2 but scant since that time. Our associate at Big Mountain...
2011 Review of Rayno Life Science Portfolios Next Week
Stay the Course for Now We will review our holdngs next week and rebalance if necessary. Overall it has been a good week with biotech indices up about 2%. Late January is always a good time for a...
Microfluidics (MFLU.OB) Acquired for $1.35/Share
Microfluidics announced today that it signed a definitive merger agreement with IDEX Corp.(IEX) for $1.35 net cash to the seller subject to adjustment as provided in the merger agreement. The $1.35...